consent was obtained from the participants or their guardians before the collection of their clinical data and preparation of genomic DNA from their peripheral venous leukocytes. The cohort of 157 probands with RP, including 34 autosomal dominant RP, 27 autosomal recessive RP, 10 X-linked RP, and 86 sporadic RP, were the same as described in our previous study [15] . All 157 probands were initially diagnosed as nonsyndromic RP. The criteria for defining RP in the families was based on the oral descriptions of the features by the probands and their family members, such as poor vision and night blindness, or the clinical examination of the other RP patients; the clinical features of RP patients were similar to those of the probands and included attenuated retinal artery and pigment abnormality in the mid-peripheral retina. Whole exome sequencing was performed by the NimbleGen SeqCap EZ Exome (44M) array and Illumina Genome Analyzer II platform with a sequencing depth of 60-fold, as described previously [15, 18, 19] .
A total of 221 genes were listed in RetNet, accessed on January 27, 2014. Of these, 60 of the 62 genes with known association with RP had been analyzed in our previous study; the remaining two were not analyzed because EMC1 was not captured and FSCN2 (MIM: 607643) was confirmed not to be an RP gene [20] . Of the remaining 159 genes, the following 30 were not included in this study: 1) nine genes associated with age-related macular degeneration, since no evidence shows that these genes were associated with monogenetic retinal diseases; 2) seven genes encoded by mitochondrial DNA that were not captured by the NimbleGen SeqCap EZ Exome (44M) array; and 3) CHM (MIM: 300390), CYP4V2 (MIM: 608614), and 12 genes associated with Leber congenital amaurosis (LCA) that were independently analyzed in our previous studies [16, 17, 21] . Ultimately, 129 genes were included in this study. All genes screened in the earlier studies and in the current study are listed in Appendix 1.
Variants in the 129 genes were selected based on the data set from whole exome sequencing. Candidate variants were filtered out with the following multiple-step bioinformatics analysis: 1) the SNPs and short indels in the exome region were filtered against data from dbSNP132, the 1000 Genome Project, HapMap, the YH project, and the Exome Variant Server, removing minor allele frequency (MAF) values that were greater than 0.01, the frequency based on the incidence of RP (1/4000), and the fraction of heterozygotes in Hardy-Weinberg equilibrium; 2) excluded non-coding variants without altering splicing sites predicted by BDGP; 3) excluded the synonymous variants without altering splicing sites in the genes; 4) excluded missense variants predicted to be benign by both Polyphen-2 and SIFT in autosomal dominant and X-linked genes; and 5) compared with the whole exome sequencing data of 633 individuals in ethnicmatched regions without retinal degeneration.
Sanger sequencing was used to confirm the candidate variants with primer pairs targeting the fragments encompassing the candidate variants. Primers (Appendix 2) were designed using Primer3 [22] . The procedures used for amplification, sequencing, and analysis of the target fragments were as previously described [18, 19] . Segregation analysis of potential pathogenic variants were performed in available family members. Candidate causative mutations were validated in 192 normal Chinese individuals.
RESULTS
Multiple-step bioinformatics analysis was used to select 90 candidate variants from the 129 genes from the whole exome sequencing of the 157 patients. Of the 90 variants, 83 (92%) were confirmed by Sanger sequencing, while the other 7 (8%) with the low sequencing depth were false-positives. Of the 83, 76 (Appendix 3) were considered as unlikely causes of RP for the following reasons: 1) mutations that are more likely to be pathogenic have already been detected in one of the 72 genes related to RP and LCA or CHM in our previous studies [15] [16] [17] ; 2) the genotype did not match the patterns of inheritance; 3) the variants did not segregate with the disease; 4) the variants were found in controls or in the 1000 Genome/ Exome Variant Server database with a frequency higher than the prevalence rate of RP as causative mutations; 5) the variants were unlikely or less likely to be pathogenic mutations based on previous reports; 6) the phenotype did not match the genotype; and 7) the other allele for compound heterozygous variants if one of them was confirmed to be a false-positive. The remaining seven variants involved three genes: BBS2 (MIM: 606151), INPP5E (MIM: 613037), and CACNA1F (MIM: 300110); these were considered to be potentially causative in five patients ( Figure 1 and Table 1 ), including three patients with homozygous (1) or compound heterozygous (2) mutations in genes associated with an autosomal recessive trait, and two patients with hemizygous mutation in genes associated with an X-linked trait. Limited cosegregation analysis and family structure did not reject the association of the mutations with RP ( Figure 1 ). The carriers with the heterozygous mutant alleles were evaluated as asymptomatic for the disease through follow-up examinations and revisits by phone calls. All 7 mutations were absent in the 192 normal individuals (Table 1) .
Clinical data of the five patients with RP are summarized in Table 2 . Ocular signs and symptoms in all five patients met the diagnosis of RP (Figure 2 ). Two patients (RP237 and RP240) had BBS2 mutations; one had RP alone with a missense mutation and a nonsense mutation, while the other one had BBS syndrome (misdiagnosed as RP) and a homozygous nonsense mutation. The patient (RP374) with INPP5E mutations had typical RP but without noticeable extraocular or systemic anomalies (unfortunately, a brain CT scan was not available). The two patients (RP401 and RP403) with CACNA1F truncation mutations showed generalized retinal degeneration involving both rods and cones.
DISCUSSION
Seven putative pathogenic mutations in 3 of the 129 genes known to associate with other forms of retinal dystrophy Table 2 .
have been detected in 5 of 157 (3%, Figure 3 ) patients with RP based on whole exome sequencing. These mutations are predicted to be causative based on bioinformatics analysis and comparison with previously reported mutations in BBS2, INPP5E, and CACNA1F. Ocular changes in the five patients with mutations are consistent with RP ( Figure 2 and Table  2 ). These findings suggest that a small portion of RP may be caused by mutations in genes responsible for other forms of retinal dystrophy.
Systematic analysis of genes responsible for other forms of retinal dystrophy in patients with RP has been limited. Previously, genotyping microarrays were used to analyze all known mutations in several genes associated with retinal dystrophy in patients with retinal dystrophy [23] [24] [25] . However, only a small subset of known mutations are covered by this technology, and the total diagnostic rate is less than 15% [26, 27] . Systematic analysis of most of these genes in patients with RP or hereditary retinal dystrophies has been conducted using targeted-capture sequencing. The frequencies of detected mutations in these genes are from 4% to 11% [13, 28, 29] . Analysis of individual genes also revealed that mutations in a few genes known to associate with other forms of retinal dystrophy also cause a fraction of RP [12, 30, 31] . This suggests that the frequency of mutations in genes associated with other forms of retinal dystrophy in our cohort of RP is close to that reported previously.
Consistencies and inconsistencies were both evident in the associations between the phenotypes and the identified mutations in the five patients. The two patients with BBS2 mutations included one with nonsyndromic RP that has missense and nonsense mutations, while the other with Bardet-Biedl syndrome had a homozygous nonsense mutation. A missense and a nonsense mutation in BBS2 have previously been reported to be responsible for Bardet-Biedl syndrome [32, 33] , and two missense mutations in BBS2 have been described recently in patients with nonsyndromic RP [34] . Comparisons of these findings suggest that the phenotypes might be affected by the type of mutation. Further study is needed to clarify this interesting issue.
The patient (RP374) with INPP5E mutations had no other noticeable signs of systemic anomalies, although mutations in INPP5E have been identified in patients with MORM syndrome [35] and Joubert syndrome [36] . Unexpectedly, two patients (RP401 and RP403) with RP had hemizygous truncation mutations in CACNA1F; these kinds of mutations have been identified in patients with congenital stationary night blindness [37, 38] , cone-rod dystrophy [39] , and Aland Island eye disease [40] , but not in patients with RP. The association of CACNA1F mutations with RP in these two patients is uncertain, although the phenotype in the patients is consistent with RP, and mutations in CACNA1F are predicted to be null.
Overall, mutations in all known genes-including these 129 genes associated with other forms of retinal dystrophy, 72 genes related to RP and LCA, and CHM-could be identified in less than 58% of 157 patients with RP. In each of the disease categories, mutations were detected in 71% (24/34) autosomal dominant RP, 48% (13/27) autosomal recessive RP, 80% (8/10) X-linked RP, and 53% (46/86) sporadic RP. Over 42% of the patients without identified mutations might carry other pathogenic variants in the noncoding regions of the corresponding genes, or may have gross deletion involving whole exons that might be missed by whole exome sequencing and Sanger sequencing, or may be caused by mutations in novel genes yet to be identified. The information about these patients without identified mutations is a valuable resource for seeking out new genes that are responsible for RP.
APPENDIX 1. GENOMIC INFORMATION OF ALL THE GENES RESPONSIBLE FOR OTHER FORMS OF RETINAL DYSTROPHY IN THE EARLIER STUDIES AND THE CURRENT STUDY.
To access these data, click or select the words "Appendix 1".
APPENDIX 2. PRIMERS USED IN SANGER SEQUENCING.
To access these data, click or select the words "Appendix 2".
APPENDIX 3. OTHER VARIANTS DETECTED IN 129 GENES RESPONSIBLE FOR OTHER FORMS OF RETINAL DYSTROPHY FROM THE 157 UNRELATED PATIENTS WITH RETINITIS PIGMENTOSA.
To access these data, click or select the words "Appendix 3".
